Arena Pharmaceuticals, Inc. Financials

Market Capitalization $6.17 Billion as of March 1, 2022

Valuations Metrics as of Jan. 25, 2025

Trailing PE
Forward PE	-13.10
Price to Sales TTM	$114172.66
Price to Book MRQ	$9.14
Enterprise to Revenue	104928.96
Enterprise to EBITDA	-10.46

Financial Reports as of Dec. 31, 2021

Financials

Fiscal Year Ends	2021-12-31
Most Recent Quarter	2021-12-31
Profit Margin	0.00%
Operating Margin	-1010483.30%
Return on Assets TTM	-34.53%
Return on Equity TTM	-70.30%

Income Statement

Revenue TTM	$54,000
Revenue per Share TTM	$0.00
Quarterly Revenue Growth	45.90%
Gross Profit TTM	$-419,455,000
EBITDA	$-541,788,992
Net Income to Common TTM	$-616,433,024
Diluted EPS TTM	$-10.14
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	$550,468,992
Total Cash per Share MRQ	$8.93
Total Debt MRQ	$
Total Debt to Equity MRQ	7.62
Current Ratio MRQ	8.59
Book Value per Share MRQ	$10.94

Cash Flow

Operating Cash Flow TTM	$-452,016,000
Levered Free Cash Flow TTM	$-248,322,496

ARNA Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	61,659,400
Float Shares	61,523,118
Avg 10 Volume	2,246,042
Avg 30 Volume	None
Shares Short	6,023,756
Short Ratio	5.79
Short % of Shares	11.32%
% Held by Insiders	0.27%
% Held by Institutions	83.86%

Stock Price Summary

Beta	0.55
Fifty Two Week Low	$45.50
Fifty Two Week High	$100.00
Fifty Two Week Change	0.49%
Day 50 MA	$93.49
Day 200 MA	$70.91

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	2017-06-19
Ex Dividend Date
Last Split Factor
Last Split Date	2017-06-19